Overview of renal osteodystrophy in Brazil: a cross-sectional study

Abstract Introduction: The epidemiologic profile of renal osteodystrophy (ROD) is changing over time and cross-sectional studies provide essential information to improve care and health policies. The Brazilian Registry of Bone Biopsy (REBRABO) is a prospective, nationalmulticenter cohort that inclu...

Full description

Bibliographic Details
Main Authors: Cinthia E.M. Carbonara, Noemi A.V. Roza, Luciene M. dos Reis, Aluízio B. Carvalho, Vanda Jorgetti, Rodrigo Bueno de Oliveira
Format: Article
Language:English
Published: Sociedade Brasileira de Nefrologia 2023-05-01
Series:Brazilian Journal of Nephrology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002023005016501&lng=en&tlng=en
_version_ 1797830878962909184
author Cinthia E.M. Carbonara
Noemi A.V. Roza
Luciene M. dos Reis
Aluízio B. Carvalho
Vanda Jorgetti
Rodrigo Bueno de Oliveira
author_facet Cinthia E.M. Carbonara
Noemi A.V. Roza
Luciene M. dos Reis
Aluízio B. Carvalho
Vanda Jorgetti
Rodrigo Bueno de Oliveira
author_sort Cinthia E.M. Carbonara
collection DOAJ
description Abstract Introduction: The epidemiologic profile of renal osteodystrophy (ROD) is changing over time and cross-sectional studies provide essential information to improve care and health policies. The Brazilian Registry of Bone Biopsy (REBRABO) is a prospective, nationalmulticenter cohort that includes patients with chronic kidney disease (CKD) undergoing bone biopsy. REBRABO aims to provide clinical information on ROD. The main objective of this subanalysis was to describe the profile of ROD, including clinically relevant associations. Methods: From Aug/2015 to Dec/2021, 511 patients with CKD who performed bone biopsy were included in the REBRABO platform. Patients with no bone biopsy report (N = 40), GFR > 90 mL/min (N = 28), without asigned consent (N = 24), bone fragments inadequate for diagnosis (N = 23), bone biopsy indicated by a specialty other than nephrology (N = 6), and < 18 years old (N = 4) were excluded. Clinical-demographic data (e.g., age, sex, ethnicity, CKD etiology, dialysis vintage, comorbidities, symptoms, and complications related to ROD), laboratory (e.g., serum levels of total calcium, phosphate, parathormone, alkaline phosphatase, 25-hydroxyvitamin D, and hemoglobin), and ROD (e.g., histological diagnosis) were analyzed. Results: Data from 386 individuals were considered in this subanalysis of REBRABO. Mean age was 52 (42–60) years; 198 (51%) were male; 315 (82%) were on hemodialysis. Osteitis fibrosa (OF) [163 (42%)], adynamic bone disease (ABD) [96 (25%)] and mixed uremic osteodystrophy (MUO) [83 (21%)] were the most frequent diagnosis of ROD in our sample; 203 (54%) had the diagnosis of osteoporosis, 82 (56%) vascular calcification; 138 (36%) bone aluminum accumulation, and 137 (36%) iron intoxication; patients with high turnover were prone to present a higher frequency of symptoms. Conclusions: A high proportion of patients were diagnosed with OF and ABD, as well as osteoporosis, vascular calcification and clinical symptoms.
first_indexed 2024-04-09T13:43:10Z
format Article
id doaj.art-df8a80dda1fc4fb4a5df5aab2fd26283
institution Directory Open Access Journal
issn 2175-8239
language English
last_indexed 2024-04-09T13:43:10Z
publishDate 2023-05-01
publisher Sociedade Brasileira de Nefrologia
record_format Article
series Brazilian Journal of Nephrology
spelling doaj.art-df8a80dda1fc4fb4a5df5aab2fd262832023-05-09T07:35:05ZengSociedade Brasileira de NefrologiaBrazilian Journal of Nephrology2175-82392023-05-0110.1590/2175-8239-jbn-2022-0146enOverview of renal osteodystrophy in Brazil: a cross-sectional studyCinthia E.M. Carbonarahttps://orcid.org/0000-0003-2786-9200Noemi A.V. Rozahttps://orcid.org/0000-0003-3992-0368Luciene M. dos Reishttps://orcid.org/0000-0001-8476-6780Aluízio B. Carvalhohttps://orcid.org/0000-0001-5907-7764Vanda Jorgettihttps://orcid.org/0000-0002-4824-8879Rodrigo Bueno de Oliveirahttps://orcid.org/0000-0002-8273-6200Abstract Introduction: The epidemiologic profile of renal osteodystrophy (ROD) is changing over time and cross-sectional studies provide essential information to improve care and health policies. The Brazilian Registry of Bone Biopsy (REBRABO) is a prospective, nationalmulticenter cohort that includes patients with chronic kidney disease (CKD) undergoing bone biopsy. REBRABO aims to provide clinical information on ROD. The main objective of this subanalysis was to describe the profile of ROD, including clinically relevant associations. Methods: From Aug/2015 to Dec/2021, 511 patients with CKD who performed bone biopsy were included in the REBRABO platform. Patients with no bone biopsy report (N = 40), GFR > 90 mL/min (N = 28), without asigned consent (N = 24), bone fragments inadequate for diagnosis (N = 23), bone biopsy indicated by a specialty other than nephrology (N = 6), and < 18 years old (N = 4) were excluded. Clinical-demographic data (e.g., age, sex, ethnicity, CKD etiology, dialysis vintage, comorbidities, symptoms, and complications related to ROD), laboratory (e.g., serum levels of total calcium, phosphate, parathormone, alkaline phosphatase, 25-hydroxyvitamin D, and hemoglobin), and ROD (e.g., histological diagnosis) were analyzed. Results: Data from 386 individuals were considered in this subanalysis of REBRABO. Mean age was 52 (42–60) years; 198 (51%) were male; 315 (82%) were on hemodialysis. Osteitis fibrosa (OF) [163 (42%)], adynamic bone disease (ABD) [96 (25%)] and mixed uremic osteodystrophy (MUO) [83 (21%)] were the most frequent diagnosis of ROD in our sample; 203 (54%) had the diagnosis of osteoporosis, 82 (56%) vascular calcification; 138 (36%) bone aluminum accumulation, and 137 (36%) iron intoxication; patients with high turnover were prone to present a higher frequency of symptoms. Conclusions: A high proportion of patients were diagnosed with OF and ABD, as well as osteoporosis, vascular calcification and clinical symptoms.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002023005016501&lng=en&tlng=enRenal Insufficiency, ChronicChronic Kidney Disease-Mineral and Bone Disorder
spellingShingle Cinthia E.M. Carbonara
Noemi A.V. Roza
Luciene M. dos Reis
Aluízio B. Carvalho
Vanda Jorgetti
Rodrigo Bueno de Oliveira
Overview of renal osteodystrophy in Brazil: a cross-sectional study
Brazilian Journal of Nephrology
Renal Insufficiency, Chronic
Chronic Kidney Disease-Mineral and Bone Disorder
title Overview of renal osteodystrophy in Brazil: a cross-sectional study
title_full Overview of renal osteodystrophy in Brazil: a cross-sectional study
title_fullStr Overview of renal osteodystrophy in Brazil: a cross-sectional study
title_full_unstemmed Overview of renal osteodystrophy in Brazil: a cross-sectional study
title_short Overview of renal osteodystrophy in Brazil: a cross-sectional study
title_sort overview of renal osteodystrophy in brazil a cross sectional study
topic Renal Insufficiency, Chronic
Chronic Kidney Disease-Mineral and Bone Disorder
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002023005016501&lng=en&tlng=en
work_keys_str_mv AT cinthiaemcarbonara overviewofrenalosteodystrophyinbrazilacrosssectionalstudy
AT noemiavroza overviewofrenalosteodystrophyinbrazilacrosssectionalstudy
AT lucienemdosreis overviewofrenalosteodystrophyinbrazilacrosssectionalstudy
AT aluiziobcarvalho overviewofrenalosteodystrophyinbrazilacrosssectionalstudy
AT vandajorgetti overviewofrenalosteodystrophyinbrazilacrosssectionalstudy
AT rodrigobuenodeoliveira overviewofrenalosteodystrophyinbrazilacrosssectionalstudy